Home - Products - Others - Other Targets - 3,4-(Methylenedioxy)cinnamic acid

3,4-(Methylenedioxy)cinnamic acid

CAS No. 2373-80-0

3,4-(Methylenedioxy)cinnamic acid ( 3-(Benzo[d][1,3]dioxol-5-yl)acrylic acid )

Catalog No. M28635 CAS No. 2373-80-0

3,4-(Methylenedioxy)cinnamic acid is a plant-derived compound first extracted from roots of Asparagus officinalis and further characterized as an allelochemical.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 49 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    3,4-(Methylenedioxy)cinnamic acid
  • Note
    Research use only, not for human use.
  • Brief Description
    3,4-(Methylenedioxy)cinnamic acid is a plant-derived compound first extracted from roots of Asparagus officinalis and further characterized as an allelochemical.
  • Description
    3,4-(Methylenedioxy)cinnamic acid is a plant-derived compound first extracted from roots of Asparagus officinalis and further characterized as an allelochemical.
  • Synonyms
    3-(Benzo[d][1,3]dioxol-5-yl)acrylic acid
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Ketohexokinase (KHK)
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2373-80-0
  • Formula Weight
    192.2
  • Molecular Formula
    C10H8O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OC(C=Cc(cc1)cc2c1OCO2)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Huard K, et al. Discovery of Fragment-Derived Small Molecules for in Vivo Inhibition of Ketohexokinase (KHK). J Med Chem. 2017 Sep 28;60(18):7835-7849.
molnova catalog
related products
  • LDN-27219

    LDN-27219 is a potent hTGase inhibitor with IC50 of 0.6 uM.

  • Cyperotundone

    Cyperotundone is a natural product from Cyperus rotundus.

  • TBMP

    TBMP is the viral envelope protein hemagglutinin (HA)-mediated entry novel inhibitor.